Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Steroid lactone produced by Withania somnifera;...
SMAC mimetic; PXR agonist, IAP inhibitor.
Steroidal alkaloid found in Veratrum and Fritil...
5-HT2A and TRPV1 antagonist, potential α1-adre...
Diterpene originally found in Rabdosia.
Xanthine derivative; PDE inhibitor.
Flavonoid glycoside found in citrus fruit.
Phenylethylamine; β2-adrenergic agonist, SK/BK...
PAK4 inhibitor.
Imidazole; HMG-CoA reductase, 14-α demethylase...
Triterpene aglycone found in Radix Astragali; t...
Endogenous neuropeptide, involved in opioid sig...
Glutathione-sulforaphane conjugate, antioxidant...
Flavonol found in fruits and vegetables; COMT i...
Folate analog; thymidylate synthase inhibitor.<...
Methylated derivative of n-octyl-caffeate.
Triterpene saponin found in species of Panax; P...
Synthetic peptide, vasopressin derivative; V2 a...
Antioxidant shown to improve renal function.
Isoxazole derivative; HSP90 inhibitor.